Developmental Therapeutics
Developmental therapeutics involves the research and development of new cancer treatments, including drugs, biological therapies, and novel approaches.
Risk Factors for Immune Checkpoint Inhibitor–Related Myocarditis: An Integrative Review
Sara M. Otto, MS, APRN, FNP-BC, AOCNP®, Ashely L. Martinez, DNP, APRN, FNP-BC, AOCNP®, CBCN, CPHQ, NEA-BC, and Joyce E. Dains, DrPH, JD, APRN, FNP-BC, FNAP, FAANP, FAAN
March 25, 2024
The Role of the Research Advanced Practice Provider in CAR T-Cell Clinical Trials
Ly Dsouza, PA-C, MPAS
January 18, 2023
New Frontiers: The Role of CAR T-Cell Therapy in Multiple Myeloma
Alli McClanahan, APRN, and Megan Spychalla, PA-C
April 21, 2022
An AP Perspective on Infusion Reactions in the Era of Immunotherapy
Carrie Peterson, DNP, RN, AGNP-c
April 21, 2022
Immunotherapy for the Treatment of Triple-Negative Breast Cancer
Sara M. Tolaney, MD, MPH, and Lindsay Shaw, ANP-BC, AOCNP®
April 21, 2022
Myasthenia Gravis: A Rare Neurologic Complication of Immune Checkpoint Inhibitor Therapy
Yelena Shames, MS, ACNP-BC, CNRN, CTNL, Mimma Errante, MS, ANP-C, OCN®, and Nana Prempeh Keteku, MS, ANP-BC
March 19, 2022
Management of Hematologic Adverse Events Associated With Immune Checkpoint Inhibitors
Barbara Barnes Rogers, CRNP, MN, AOCN®, ANP-BC, Carolyn Zawislak, MPAS, PA-C, and Victoria Wong, PA-C
May 19, 2021
Immune Checkpoint Inhibitors: Common Questions About Uncommon Adverse Events
Presented by Lisa Kottschade, APRN, MSN, CNP
April 20, 2021
An Evaluation of the Use of Corticosteroids for the Management of Immune-Mediated Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
Adrian Tsui,(1) PharmD, Lindsay Edmondson,(2) PharmD, BCOP, Justin Julius,(3) PharmD
March 15, 2021
The Role of Advanced Practice Providers and Telemedicine in Reinventing Care: The Transition of a CAR T-Cell Transplantation Program to the Outpatient Setting
Kiersten LeBar,(1) DNP, MMHC, APRN, CPNP-AC, Sarah Murawski,(2) MPAS, PA-C, Sherlyn Umayam,(2) MSN, AGACNP-BC, AOCNP®, and Virginia Quinn,(2) MSN, AGACNP-BC
September 23, 2020
Pseudoprogression and Immunotherapy Phenomena
Elizabeth S. Waxman, RN, MSN, AOCN®, ANP-BC, and Donna Lee Gerber, CNS
September 23, 2020
Immune Checkpoint Inhibitor–Based Therapy as a Backbone in Cancer Treatment
Presented by Krista M. Rubin,(1) MS, FNP-BC, and Anthony J. Olszanski,(2) MD, RPh
April 21, 2020
Adoptive Cell Therapies: Keeping Pace With New and Emerging Advances
Presented by Patricia Mangan, RN, MSN, CRNP, and Edward Stadtmauer, MD
April 20, 2020
Beyond CAR T-Cell Therapy: Continued Monitoring and Management of Complications
Victoria Reiser, RN, BSN, BMTCN, OCN®
March 18, 2020
The Role of Advanced Practitioners in Optimizing Clinical Management and Support of Patients With Cytokine Release Syndrome From CAR T-Cell Therapy
Sherry Adkins, MSN, ANP-C
November 20, 2019
Axicabtagene Ciloleucel: The First FDA-Approved CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma
Amber C. King, PharmD, BCOP, and Jennifer S. Orozco, PharmD
November 20, 2019
The Advanced Practice Provider Perspective: Treating Patients With Immuno-Oncology Combination Therapy Across Tumor Types
Brianna Hoffner,(1) MSN, ANP-BC, AOCNP®, Renae Vaughn,(2) MSN, ANP-C, AOCNP®, Maureen Reed,(3) MSN, ANP-C, AOCNP®, and Melinda S. Weber,(4) DNP, RN, APN, AOCN®
May 21, 2019
CAR T-Cell Therapy and the Pharmacology of Managing Cytokine Release Syndrome
Presented by Jae Park, MD, and Amber C. King, PharmD, BCOP
April 19, 2019
Tisagenlecleucel: The First CAR on the Highway to Remission for Acute Lymphoblastic Leukemia
Craig W. Freyer, PharmD, BCOP
July 24, 2018
Current Issue
Immediate Patient Access to Test Results and the Impact on Advanced Practitioners
Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO
November 26, 2024
Obinutuzumab Infusion-Related Reactions Multicenter Retrospective Evaluation of Incidence, Severity, and Risk Factors
Erin Hickey Zacholski, PharmD, BCOP, Sarah Rugh, PharmD Candidate, Jenna Marshall, PharmD Candidate, Et al.
November 26, 2024
Pancreatic Cancer The Advanced Practitioners Role in Early Diagnosis and Management
Lindsay Knox, FNP-C
November 26, 2024